Brief: Mallinckrodt And Endo To Combine To Create A Global, Scaled, Diversified Pharmaceuticals Leader

Endo

13/03/2025 10:34

March 13 (Reuters) - Endo Inc NDOI.PK:

MALLINCKRODT AND ENDO TO COMBINE TO CREATE A GLOBAL, SCALED, DIVERSIFIED PHARMACEUTICALS LEADER

ENDO INC - SHAREHOLDERS TO RECEIVE $80 MILLION IN CASH FROM DEAL

ENDO INC - COMBINED COMPANY EXPECTED TO BE LISTED ON NYSE

ENDO INC - MALLINCKRODT SHAREHOLDERS TO OWN 50.1% OF COMBINED COMPANY

ENDO INC - COMBINATION EXPECTED TO GENERATE $150 MILLION ANNUAL SYNERGIES BY YEAR 3

ENDO INC: PROPOSED DEAL FOR FOR AN IMPLIED PRO FORMA ENTERPRISE VALUE OF $6.7 BILLION

ENDO INC - SIGGI OLAFSSON TO BECOME CEO OF COMBINED COMPANY

ENDO INC - MALLINCKRODT & ENDO TO FINANCE DEAL WITH CASH ON HAND & $900 MILLION PROVIDED TO ENDO BY GOLDMAN SACHS

Source text: ID:nPn7kh3lha

Further company coverage: NDOI.PK

 ((Reuters.Briefs@thomsonreuters.com;))